Fudan University
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT)
- Conditions
- Ewing's Sarcoma
- Interventions
- Drug: VCR, CTX, ADM; IFO, VP-16
- First Posted Date
- 2007-12-06
- Last Posted Date
- 2009-07-07
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 10
- Registration Number
- NCT00568464
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma
- Conditions
- Lymphoma
- Interventions
- Drug: IFO, VP-16, DDP, DXM
- First Posted Date
- 2007-12-06
- Last Posted Date
- 2010-09-08
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 60
- Registration Number
- NCT00568607
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection
- Conditions
- Hepatocellular CarcinomaNeoplasm Metastasis
- Interventions
- Other: No other preventive treatment
- First Posted Date
- 2007-11-21
- Last Posted Date
- 2010-07-21
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 290
- Registration Number
- NCT00561522
- Locations
- 🇨🇳
Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China
Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria
- First Posted Date
- 2007-11-06
- Last Posted Date
- 2007-11-06
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 220
- Registration Number
- NCT00554125
- Locations
- 🇨🇳
Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China
Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer
- Conditions
- Breast NeoplasmsAdjuvantChemotherapy
- Interventions
- First Posted Date
- 2007-09-06
- Last Posted Date
- 2007-09-06
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 603
- Registration Number
- NCT00525642
- Locations
- 🇨🇳
Beijing 307 Hospital, Beijing, Beijing, China
🇨🇳No2 affiliated hospital of Sun Yat-sen medical Univesity, Guangzhou, Guangdong, China
🇨🇳Liaoning Province Cancer Hospital, Shenyang, Liaoning, China
Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis
- First Posted Date
- 2007-09-05
- Last Posted Date
- 2010-09-14
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 60
- Registration Number
- NCT00524849
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
The Protocol of Enhanced Recovery After Surgery in Colorectal Surgery
- Conditions
- Colorectal Surgery
- Interventions
- Procedure: enhanced recovery after surgery (ERAS) protocolProcedure: control
- First Posted Date
- 2007-07-10
- Last Posted Date
- 2009-03-25
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 500
- Registration Number
- NCT00498290
- Locations
- 🇨🇳
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Interventions
- Device: Radiation Therapy
- First Posted Date
- 2007-07-06
- Last Posted Date
- 2008-10-21
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 32
- Registration Number
- NCT00497250
- Locations
- 🇨🇳
Fudan University, Cancer Hospital, Department of Radiation Oncology, Shanghai, China
Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma
- Conditions
- Hepatocellular Carcinoma
- First Posted Date
- 2007-04-16
- Last Posted Date
- 2007-10-31
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 220
- Registration Number
- NCT00460681
- Locations
- 🇨🇳
Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China